Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Product Type, Application & End-User The global dental biomaterials market will witness a robust CAGR of 7.29%, valued at $7.70 billion in 2021, expected to appreciate and reach $14.5 billion by 2030, confirms Strategic Market Research. Dental biomaterials are fabricated structures that restore the decayed, damaged, or fractured teeth and promote the tissue regeneration process. Within the process, there include biocompatible synthetic materials and natural tissues that are used to treat various tooth decay and damage problems. There are different types of biocompatible synthetic dental materials available such as metals, polymers, ceramics, and composite structures, whereas the natural tissues include enamel, cementum, dentin, bone, and other intraoral tissues. According to WHO 2020 update, the estimated oral diseases affected nearly 3.5 billion people worldwide, with untreated dental caries in the permanent teeth as the most common health condition. The factors responsible for the global dental biomaterials market growth are an increase in dental disorders, growth in dental tourism, penetration of dental implants, and an increase in the income of people. North America has been a significant contributor to the market. Drivers - Increase in the Burden of Dental Disorders, Rise in Geriatric Population, and Impact of Dental Implant Tourism. The increase in the burden of dental disorders such as periodontal disease, tooth decay, oral cancer, dental caries, and halitosis, among all other diseases, are driving the market growth. As per the reports of the center for disease control and prevention (CDC), the signs of gum disease are present in 46 percent of all adults aged 30 years or older, and severe gum disease affects about 9% of adults. About 26% of adults in the US have untreated tooth decay. Furthermore, as per the National Institute of Dental and Craniofacial Research report, 92 percent of adults between the ages 20 and 64 have dental caries in their permanent teeth, with an average severity of 3.28 decayed or missing permanent teeth, 13.65 decayed and missing permanent surfaces. Dental implant tourism is a growing business due to its affordability. Patients Beyond Borders, a company researching medical procedures in other countries, reports that U.S. patients can expect to save 40%–65% in Mexico, 45%–65% in Costa Rica, and 50%–75% in Thailand. Moreover, it can increase the adoption of dental procedures among the targeted patient audience, which in turn is fueling the demand for the market. According to the US Census, the number of US adults aged 65 years or older is expected to grow to 98 million by 2060, i.e., 24 percent of the overall population. An increase in the geriatric population suffering from oral diseases such as oral cancer, tooth decay, gum disease, etc., is a significant driver of the market's growth. The Centre for disease control and prevention asserts that about 2 in 3 adults aged 65 years or older, i.e., almost 68 percent of the aged population, have gum disease and oral cancers and are diagnosed at a median age of 62 years. With the growing usage of J dent dental labs and 3m dental materials globally, the market for Dental Biomaterials Market is expected to rise significantly. Restraints - High Cost and Imposition of Regulations The imposition of regulations and the high cost of the procedures are challenging the overall market growth. Opportunities - Focus on Government Policies, Investments, and Innovations in the Market In recent years, various government bodies are highly focusing on the research and development of the market by making significant investments in terms of advanced dental biomaterials such as the use of nanoparticles as biomaterials in dentistry, Nanoparticulate hydroxyapatite for boner therapy applications which is likely to create a wide range of growth opportunities for the market in the upcoming years. The regulatory changes in the US and the adoption of policies related to dental biomaterials are anticipated to create significant opportunities. The American Dental Association has adopted the policies such as Public Health Emergencies (COVID-19), Dental Amalgam, and Tobacco Use and Vaping. Moreover, the further increase in the number of policies can ease the regulations in the dental market in the future. Market Analysis Of Different Segments Covered in the Report Based on Product Type Metallic Biomaterial Titanium Stainless steel Chromium alloys Others Ceramic Biomaterial Metal- ceramic Biomaterial Natural Biomaterial Based on Application Biomaterials in Implantology Biomaterials in Prosthodontics Biomaterials in Orthodontics Others Based on End-User Dental Product Manufacturers Dental Laboratories Dental Hospitals and Clinics Dental academics and research institutes Regional Coverage Analysis North America US Canada Mexico Rest of North America Europe Germany France UK Italy Rest of Europe Asia Pacific Australia Japan India China Rest of Asia Pacific LAMA Brazil Saudi Arabia South Africa Rest of LAMEA Segments Analysis & Insights Based on the product type, the metallic biomaterials segment dominated the overall market with a steady CAGR in the estimated period. As per the article published in November 2021, “Metallic Biomaterials for Medical Applications,” titanium alloys are widely used for dental and implant materials due to their superior biocompatibility, corrosion resistance, and specific strength as compared to other metallic implant materials. The factors attributed to the growth of this segment are the increasing penetration of dental implants—high strength of materials, and wide applications of metallic biomaterials in dentistry. Based on the Application, the Biomaterials in the implantology segment dominated the overall dental biomaterials market. With a decent CAGR, the market in the forecasted period is expected to rise due to the penetration of global dental implants, increase in demand for cosmetic dentistry, high price and volume requirements, and the growing tourism in the emerging markets. According to the statistics of total freedom implants, dental implants are more popular, with a 98 percent success rate, as approximately 156 million Americans have at least one missing tooth. Based on End-user, the Dental laboratories segment dominated the market with a significant market share in the forecasted period. As per the IBIS world, 2020,9300 dental laboratories are present in the US. This is attributed to increasing dental practice, tooth disorders, and general awareness about oral hygiene. North America has captured the largest market share based on Region with a robust CAGR in the forecasted period. As per the American Dental Association report, in 2020, more than 5 million US seniors aged 65 to 74 had complete tooth loss, with nearly 3 million suffering from edentulous and Tooth loss, which is a primary problem for elderly people. Stating further, tooth decay is the most common cause of tooth loss. The vital factors responsible for the development of the market are the increase in product launches with the government's support, an increase in the burden of dental disorders, and the presence of a large no of geriatric population. The Global Burden of Disease survey reports that the Asia Pacific showed a huge burden of oral diseases, with around 3 to 6.5 out of 10 people suffering from oral diseases. Dental Biomaterials Market Competitive Landscape Analysis The competitive landscape analysis provides information about the crucial competitors that are prevailing in the worldwide market environment. There lies intense competition in the market due to the rapid adoption of advanced healthcare technologies. 3M Company Carpenter Technology Corporation Royal DSM Zimmer Biomet Holdings Inc Straumann Holding AG Danaher Corporation Kuraray Co Ltd Henry Schein Inc Mitsui Chemicals Inc Victrex PLC Geistlich Pharma AG Dentsply Sirona Inc Medtronic PLC Ivoclar Vivadent AG GC Corporation Dental Biomaterials Market Report Coverage Report Attribute Details Forecast Period 2021-2030 The market size value in 2021 USD 7.70 Billion The revenue forecast in 2030 USD 14.5 Billion Growth rate 7.29 percent The base year for estimation 2021 Historical data 2017-2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Technology, By End User, and By Region. By Product Metallic Biomaterial, Ceramic Biomaterial, Metal- ceramic Biomaterial, Natural Biomaterial By Application Biomaterials in Implantology, Biomaterials in Prosthodontics and Biomaterials in Orthodontics By End-User Dental Product Manufacturers, Dental Laboratories, Dental Hospitals and Clinics, Dental academics, and research institutes By Region North America, Europe, Asia Pacific, and LAMEA Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E., etc. Company Usability Profiles 3M company, Carpenter Technology Corporation, Royal DSM, Zimmer Biomet Holdings Inc, Straumann Holding AG, Danaher Corporation, Kuraray Co Ltd, Henry Schein Inc, Mitsui Chemicals Inc, Victrex PLC, Geistlich Pharma AG, Dentsply Sirona Inc, Medtronic PLC, Ivoclar Vivadent AG and GC Corporation Recent Developments On April 2022, Sonendo, Inc., a leading dental technology company and developer of the GentleWave System, announced the launch of the CleanFlow procedure instrument. It is primarily designed to work with Sonendo’s GentleWave System, which provides a less painful and invasive alternative to traditional root canal therapy; hence, it has made the GentleWave procedure more popular compared to earlier GentleWave procedures for creating a better patient experience. In February 2022, Ultradent Products Inc launched MTApex bioceramic root canal sealer, a new endodontic product that can be used with any endodontic obturation method. MTApex bioceramic root canal sealer features an extra smooth consistency when it is delivered through Ultradent’s 29 ga Single Sideport NaviTip tip. It also provides a sealer that is bioceramic and can be used with any endodontic obturation method. In April 2021, Ultradent Products Inc., a developer and manufacturer of high-tech dental materials and equipment, purchased majority ownership in Vamasa SA de CV, a premier distributor of dental products, sharing a similar vision, value, and innovative spirit to those they serve and employ a unique opportunity to support the dental market in Mexico and to improve oral health globally. This addition of Vamasa’s impressive network of suppliers, dealers, and clinicians and their infrastructure assists Ultradent’s ability to better serve dentists in the Latin American region. In August 2021, Botiss biomaterials GmbH announced the development of next-generation dental biomaterials, a first-ever dental magnesium biomaterial to receive CE approval, providing an option for dentists seeking a mechanically robust biomaterial that will be replaced with the natural bone over a period of time. In January 2020, Pulpdent Corporation, dental research and manufacturing company based in the Greater Boston area introduced its ACTIVA Presto dental material. The new white dental filling material mimics the properties of natural teeth. ACTIVA Presto is a moisture-friendly stackable composite that holds its shape to facilitate the diffusion of bioavailable calcium, phosphate, and fluoride ions with a unique chemistry that penetrates and integrates with tooth structure for margin-free adaptation. Frequently Asked Question About This Report Who are the crucial players in the market? Some of the key players in the market are 3M Company, Carpenter Technology Corporation, Royal DSM, Zimmer Biomet Holdings Inc, Straumann Holding AG, Danaher Corporation, Kuraray Co Ltd, Henry Schein Inc, Mitsui Chemicals Inc, Victrex PLC What is the dental biomaterials market growth? The global dental biomaterials market is expected to grow at a compound annual growth rate (CAGR) of 7.29 % from 2021 to 2030 to reach USD 14.5 billion by 2030. Which region has the highest growth rate in the market? The market United States (North America) had the highest growth rate in the market in 2020. What are the crucial drivers of the market? The increase in the burden of dental disorders and dental tourism are the key drivers of the market. How big is the dental biomaterials market size? The global dental biomaterials market size was $7.70 billion in 2021 and is predicted to reach $14.5 billion by 2030, with a CAGR of 7.29%. Sources https://www.who.int/health-topics/oral-health https://www.cdc.gov/oralhealth/basics/adult-oral-health/index.html https://www.prb.org/resources/fact-sheet-aging-in-the-united-states/ https://pubmed.ncbi.nlm.nih.gov/16211157/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Dental Biomaterials Market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by region, 2021 - 2030 (USD Million) 4.4 By Product Type Business Analysis 4.4.1 Market, By Product Type, 2021 - 2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Market, By End-User, 2021 - 2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Market, By Application, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 PEST analysis 4.9.2 Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2021) 5.11.2. Trends in Application (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Dental Biomaterials Manufacturing Sites, Area Served, Product Product Type 6.3. Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Metallic Biomaterial 7.3.1. Metallic Biomaterial market, 2021 - 2030 (USD Million) 7.3.1.1 Titanium market, 2021 - 2030 (USD Million) 7.3.1.2 Stainless steel market, 2021 - 2030 (USD Million) 7.3.1.3 Chromium alloys market, 2021 - 2030 (USD Million) 7.4. Ceramic Biomaterial 7.4.1. Ceramic Biomaterial market, 2021 - 2030 (USD Million) 7.5. Metal- ceramic Biomaterial 7.5.1. Metal- ceramic Biomaterial market, 2021 - 2030 (USD Million) 7.6. Natural Biomaterial 7.6.1. Natural Biomaterial market, 2021 - 2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Dental Product Manufacturers 8.3.1. Dental Product Manufacturers market, 2021 - 2030 (USD Million) 8.4. Dental Laboratories 8.4.1. Dental Laboratories market, 2021 - 2030 (USD Million) 8.5. Dental Hospitals and Clinics 8.5.1. Dental Hospitals and Clinics market, 2021 - 2030 (USD Million) 8.6. Dental academics and research institutes 8.6.1. Dental academics and research institutes market, 2021 - 2030 (USD Million) 9. Global Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Biomaterials in Implantology 9.3.1. Biomaterials in Implantology market, 2021 - 2030 (USD Million) 9.4. Biomaterials in Prosthodontics 9.4.1. Biomaterials in Prosthodonticsmarket, 2021 - 2030 (USD Million) 9.5. Biomaterials in Orthodontics 9.5.1. Biomaterials in Orthodontics market, 2021 - 2030 (USD Million) 9.6. Other 9.6.1. Other market, 2021 - 2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America by By Product Type, 2021 - 2030 (USD Million) 10.1.2. North America by By End-User, 2021 - 2030 (USD Million) 10.1.3. North America by Application, 2021 - 2030 (USD Million) 10.1.4. North America by Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. By Product Type, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. By End-User, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. by Application, 2021 - 2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada By Product Type, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada By End-User, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada by Application, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe By Product Type, 2021 - 2030 (USD Million) 10.2.2. Europe By End-User, 2021 - 2030 (USD Million) 10.2.3. Europe by Application, 2021 - 2030 (USD Million) 10.2.4. Europe by country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. By Product Type, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. By End-User, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K. by Application, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany By Product Type, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany By End-User, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany by Application, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France By Product Type, 2021 - 2030 (USD Million) 10.2.4.3.2. France y End-User, 2021 - 2030 (USD Million) 10.2.4.3.3. France by Application, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe By Product Type, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe By End-User, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe by Application, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific By Product Type, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific By End-User, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific by Application, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific by country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China By Product Type, 2021 - 2030 (USD Million) 10.3.4.1.2. China By End-User, 2021 - 2030 (USD Million) 10.3.4.1.3. China By Application, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India By Product Type, 2021 - 2030 (USD Million) 10.3.4.2.2. India By End-User, 2021 - 2030 (USD Million) 10.3.4.2.3. India by Application, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan By Product Type, 2021 - 2030 (USD Million) 10.3.4.3.2. Japan By End-User, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan by Application, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea By Product Type, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea By End-User, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea by Application, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC By Product Type, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC By End-User, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC by Application, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America By Product Type, 2021 - 2030 (USD Million) 10.4.2. Latin America By End-User, 2021 - 2030 (USD Million) 10.4.3. Latin America Application, 2021 - 2030 (USD Million) 10.4.4. Latin America by country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil By Product Type, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil By End-User, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil by Application, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico By Product Type, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico By End-User, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico by Application, 2021 - 2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America By Product Type, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin America By End-User, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin America by Application, 2021 - 2030 (USD Million) 10.5. MEA 10.5.1. MEA By Product Type, 2021 - 2030 (USD Million) 10.5.2. MEA By End-User, 2021 - 2030 (USD Million) 10.5.3. MEA by Application, 2021 - 2030 (USD Million) 10.5.4. MEA by Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 3M company 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. CARPENTER TECHNOLOGY CORPORATION 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. ROYAL DSM 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. ZIMMER BIOMET HOLDINGS INC 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. STRAUMANN HOLDING AG 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Danaher Corporation 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Kuraray Co Ltd 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Henry Schein Inc 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. Mitsui Chemicals Inc 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Victrex PLC 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. Geistlich Pharma AG 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Dentsply Sirona Inc 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. Medtronic PLC 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. Ivoclar Vivadent AG 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development 11.15. GC Corporation 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development List of Tables (61 Tables) TABLE 1. By Product Type, 2021-2030 (USD Million) TABLE 2. FOR Metallic Biomaterial, BY REGION, 2021-2030 (USD Million) TABLE 3. FOR Ceramic Biomaterial, BY REGION, 2021-2030 (USD Million) TABLE 4. FOR Metal- ceramic Biomaterial, BY REGION, 2021-2030 (USD Million) TABLE 5. FOR Natural Biomaterial, BY REGION, 2021-2030 (USD Million) TABLE 6. By End-User, 2021-2030 (USD Million) TABLE 7. FOR Dental Product Manufacturers, BY REGION, 2021-2030 (USD Million) TABLE 8. FOR Dental Laboratories, BY REGION, 2021-2030 (USD Million) TABLE 9. FOR Dental Hospitals and Clinics, BY REGION, 2021-2030 (USD Million) TABLE 10. FOR Dental academics and research institutes, BY REGION, 2021-2030 (USD Million) TABLE 11. BY APPLICATION, 2021-2030 (USD Million) TABLE 12. FOR Biomaterials in Implantology, BY REGION, 2021-2030 (USD Million) TABLE 13. FOR Biomaterials in Prosthodontics, BY REGION, 2021-2030 (USD Million) TABLE 14. FOR Biomaterials in Orthodontics, BY REGION, 2021-2030 (USD Million) TABLE 15. BY REGION, 2021-2030 (USD Million) TABLE 16. NORTH AMERICA BY COUNTRY, 2021-2030 (USD Million) TABLE 17. NORTH AMERICA By Product Type, 2021-2030 (USD Million) TABLE 18. NORTH AMERICA By End-User, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA BY APPLICATION, 2021-2030 (USD Million) TABLE 20. EUROPE BY COUNTRY, 2021-2030 (USD Million) TABLE 21. EUROPE By Product Type, 2021-2030 (USD Million) TABLE 22. EUROPE By End-User, 2021-2030 (USD Million) TABLE 23. EUROPE BY APPLICATION, 2021-2030 (USD Million) TABLE 24. ASIA-PACIFIC BY COUNTRY, 2021-2030 (USD Million) TABLE 25. ASIA-PACIFIC By Product Type, 2021-2030 (USD Million) TABLE 26. ASIA-PACIFIC By End-User, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC BY APPLICATION, 2021-2030 (USD Million) TABLE 28. LAMEA BY COUNTRY, 2021-2030 (USD Million) TABLE 29. LAMEA By Product Type, 2021-2030 (USD Million) TABLE 30. LAMEA By End-User, 2021-2030 (USD Million) TABLE 31. LAMEA BY APPLICATION, 2021-2030 (USD Million) TABLE 32. 3M company: COMPANY SNAPSHOT TABLE 33. 3M company: OPERATING SEGMENTS TABLE 34. CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT TABLE 35. CARPENTER TECHNOLOGY CORPORATION: OPERATING SEGMENTS TABLE 36. ROYAL DSM: COMPANY SNAPSHOT TABLE 37. ROYAL DSM: OPERATING SEGMENTS TABLE 38. ZIMMER BIOMET HOLDINGS INC : COMPANY SNAPSHOT TABLE 39. ZIMMER BIOMET HOLDINGS INC : OPERATING SEGMENTS TABLE 40. STRAUMANN HOLDING AG: COMPANY SNAPSHOT TABLE 41. STRAUMANN HOLDING AG: OPERATING SEGMENTS TABLE 42. Danaher Corporation: COMPANY SNAPSHOT TABLE 43. Danaher Corporation: OPERATING SEGMENTS TABLE 44. Kuraray Co Ltd: COMPANY SNAPSHOT TABLE 45. Kuraray Co Ltd: OPERATING SEGMENTS TABLE 46. Doosan Robotics: COMPANY SNAPSHOT TABLE 47. Doosan Robotics: OPERATING SEGMENTS TABLE 48. Mitsui Chemicals Inc: COMPANY SNAPSHOT TABLE 49. Mitsui Chemicals Inc: OPERATING SEGMENTS TABLE 50. Victrex PLC: COMPANY SNAPSHOT TABLE 51. Victrex PLC: OPERATING SEGMENTS TABLE 52. Geistlich Pharma AG: COMPANY SNAPSHOT TABLE 53. Geistlich Pharma AG: OPERATING SEGMENTS TABLE 54. Denso Corporation: COMPANY SNAPSHOT TABLE 55. Denso Corporation: OPERATING SEGMENTS TABLE 56. Medtronic PLC: COMPANY SNAPSHOT TABLE 57. Medtronic PLC: OPERATING SEGMENTS TABLE 58. Ivoclar Vivadent AG: COMPANY SNAPSHOT TABLE 59. Ivoclar Vivadent AG: OPERATING SEGMENTS TABLE 60. GC Corporation: COMPANY SNAPSHOT TABLE 61. GC Corporation: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries Figure 4 Research Methodology: Metallic Biomaterials Figure 5 Product-Based Estimation Figure 6 Top 15 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2021 Figure 8 Import Data for Dental Biomaterials, By Country, 2016–2021 (USD Thousand) Figure 9 Export Data for Dental Biomaterials, By Country, 2016–2021 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 By End-User, 2019 vs. 2025 (USD Million) Figure 12 Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Share, By Product Type, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot Figure 15 Metallic Biomaterials to Witness Higher CAGR in the Product Type Segment during Forecast Period. Figure 16 Biomaterials in the implantology to Witness Higher CAGR in the Application Segment during Forecast Period. Figure 17 Dental laboratories to Witness Higher CAGR in the End-User Segment during Forecast Period. Figure 18 North America region Accounted for the Largest Share, By Regional Basis, in 2019 Figure 19 Drivers, Restraints, Opportunities, and Challenges Figure 20 North America Snapshot Figure 21 Asia Pacific Snapshot Figure 22 Vendor Dive: Evaluation Overview